Koyfin Home > Directory > Health Care > Abeona Therapeutics > Cash and Short-Term Investments

Abeona Therapeutics Cash and Short-Term Investments Chart (ABEO)

Abeona Therapeutics annual/quarterly Cash and Short-Term Investments from 2010 to 2020.
  • Abeona Therapeutics Cash and Short-Term Investments for the quarter ending June 06, 2020 was $108m a 55.58% increase of 60m year over year
  • Abeona Therapeutics Cash and Short-Term Investments for the last 12 months ending June 06, 2020 was $108m a 55.58% increase of 60m year over year
  • Abeona Therapeutics Annual Cash and Short-Term Investments for 2019 was $129m a 34.26% increase of 44m from 2018
  • Abeona Therapeutics Annual Cash and Short-Term Investments for 2018 was $85m a -62.12% decrease of -53m from 2017
  • Abeona Therapeutics Annual Cash and Short-Term Investments for 2017 was $138m a 49.81% increase of 69m from 2016
Other Balance Sheet Metrics:
  • Abeona Therapeutics Total Assets for the quarter ending September 09, 2018 was $161m a -11.33% decrease of -18m year over year
  • Abeona Therapeutics Other Liabilities for the quarter ending December 12, 2017 was $3m a -14.77% decrease of 0m year over year
  • Abeona Therapeutics Total Equity for the quarter ending September 09, 2018 was $150m a -13.21% decrease of -20m year over year
View Chart On Koyfin

Quarterly ABEO Cash and Short-Term Investments Data

06/2020$108m
03/2020$116m
12/2019$129m
09/2019$48m
06/2019$63m
03/2019$68m
12/2018$85m
09/2018$112m
06/2018$120m
03/2018$132m

Annual ABEO Cash and Short-Term Investments Data

2019$129m
2018$85m
2017$138m
2016$69m
2015$40m
2014$12m
2013$0m
2012$0m
2011$2m
2010$7m